The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

News Live: "We are hopeful that the upcoming budget will introduce progressive measures to further strengthen the real estate ...

Fortune released its World's Most Admired Companies list on Jan. 29, which included healthcare companies. The list, in its 27th year, is created in partnership between Fortune and global management ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

Four Cincinnati companies were named by Fortune as being among the world's most-admired for 2025. Fortune named Procter & ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...

The company started the first phrase of its operation in the city in January at the David Lust Accelerator Building on the Elevate Rapid City campus.

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX – Research Report) and Allakos ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...